MedTrace Logo

Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy

NCT00296621 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2007-12-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether long-term oral glutamine supplementation is effective in improving muscle mass and function in children with Duchenne muscular dystrophy (DMD).

Conditions

  • Muscular Dystrophy, Duchenne

Interventions

DRUG

L-Glutamine

L-Glutamine

DRUG

placebo

placebo

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Régis Hankard, MD, PhD · Centre Hospitalier Universitaire (CHU) de Poitiers

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-02-29
Completion
2007-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00296621 on ClinicalTrials.gov